APA (7th ed.) Citation

Kutlar, A., Reid, M. E., Inati, A., Taher, A. T., Abboud, M. R., El‐Beshlawy, A., . . . Ghalie, R. G. (2013). A dose‐escalation phase IIa study of 2,2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. American journal of hematology, 88(11), E255-E260. https://doi.org/10.1002/ajh.23533

Chicago Style (17th ed.) Citation

Kutlar, Abdullah, et al. "A Dose‐escalation Phase IIa Study of 2,2‐dimethylbutyrate (HQK‐1001), an Oral Fetal Globin Inducer, in Sickle Cell Disease." American Journal of Hematology 88, no. 11 (2013): E255-E260. https://doi.org/10.1002/ajh.23533.

MLA (9th ed.) Citation

Kutlar, Abdullah, et al. "A Dose‐escalation Phase IIa Study of 2,2‐dimethylbutyrate (HQK‐1001), an Oral Fetal Globin Inducer, in Sickle Cell Disease." American Journal of Hematology, vol. 88, no. 11, 2013, pp. E255-E260, https://doi.org/10.1002/ajh.23533.